FDA
approval
· 2019-05-20
FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Cadila Pharmaceuticals Limited)
Summary
FDA approved Cadila Pharmaceuticals Limited's supplemental application for donepezil hydrochloride, a drug used to treat Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)